Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
A phase 3 trial of Carboplatin and Ethiodized oil in Hepatocellular carcinoma, run by Sun Yat-sen University, with a status the registry has not verified recently.
Overview
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma is a phase 3 interventional study registered as NCT02755311 by Sun Yat-sen University, with 198 participants planned, started 2014-03 and due to reach its primary completion in 2016-06. Interventions recorded: liver resection, transarterial chemoembolization, carboplatin, lipiodol, epirubicin, pirarubicin, hydroxycamptothecin and fluorouracil, absorbable gelatin sponge particles. Conditions recorded: Hepatocellular Carcinoma.
Linked to the drug Ethiodized oil because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialTransarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Shares Ethiodized oil, Hepatocellular carcinoma and the tag pipeline.
- TrialEndovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
Shares Ethiodized oil, Hepatocellular carcinoma and the tag pipeline.
- TrialEfficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialOri-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialA Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialThermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialNWRD06 DNA Plasmid for HCC After Curative Resection.
Shares Hepatocellular carcinoma and the tag pipeline.
- TrialTo Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
Shares Hepatocellular carcinoma and the tag pipeline.